Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
127657-97-0
13807-91-5
14690-00-7
622-08-2
85483-97-2
70448-03-2
205445-52-9 | Boc-L-3,5-difluorophenylalanine | AA002A0B | MFCD00797555
2058-52-8 | Dibenzo[b,f][1,4]thiazepine, 2-chloro-11-(4-methyl-1-piperazinyl)- | AA002AAV | MFCD00866705
197142-34-0 | (1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid | AA002AJF | MFCD08691405
197574-95-1 | β-D-Glucopyranoside, 2-naphthalenylmethyl 2-(acetylamino)-2-deoxy- | AA002ATM | MFCD08703864
198077-69-9 | N-(3,5-difluorophenyl)formamide | AA002B6G | MFCD00034516
1984-23-2 | 4-Nitrophenylisocyanide | AA002BFA | MFCD01937394
1988-89-2 | Phenol, 4-(1-phenylethyl)- | AA002BO4 | MFCD00020181
1993-63-1 | 4-Amino-5-fluoro-2-methoxypyrimidine | AA002BZ0 | MFCD09264289
1997-80-4 | 1-(2-Bromoethyl)-3-(trifluoromethyl)benzene | AA002C7V | MFCD03092900
200195-15-9 | 3-Oxo-3,4-dihydro-2h-benzo[1,4]oxazine-6-carbaldehyde | AA002CIX | MFCD07369979